Ugandan medical researchers began selecting child volunteers in May for Africa’s latest clinical trial of a potential vaccine against malaria.
The Ugandan research, done at Iganga Hospital, will complement other human studies underway in Ghana, Gabon and Burkina Faso. The scientists are testing the effectiveness of hybrid malaria vaccine known at this stage as GMZ2.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.